Roles of 21 Genera of Human Gut Microbiota in Barrett's Esophagus Risk: A Mendelian Randomization Study

Lack of definitive evidence supports the putative hypothesis that gut microbiota dysbiosis is associated with Barrett's esophagus (BE). We conducted a two-sample Mendelian randomization study to assess the associations of 21 genera of human gut microbiota with BE. We identified independent gene...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in genetics 2022-06, Vol.13, p.894900
Hauptverfasser: Yang, Zhao, Yu, Rong, Deng, Wei, Wang, Weihu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lack of definitive evidence supports the putative hypothesis that gut microbiota dysbiosis is associated with Barrett's esophagus (BE). We conducted a two-sample Mendelian randomization study to assess the associations of 21 genera of human gut microbiota with BE. We identified independent genetic instruments for 21 genera of gut microbiota (including nine dominant genera, four core genera among individuals of European ancestry, and eight esophagus-specific genera of gut microbiota) from MiBioGen (up to 18,340 participants). We applied them to summary statistics from the largest publicly available genome-wide association study on BE (9,680 cases and 31,211 controls). We obtained the causal estimates of genetically predicted higher genera of gut microbiota and BE using the inverse variance weighting method. Sensitivity analyses included weighted median, MR-Egger, MR-RAPS, and MR-PRESSO. We found that genetically predicted higher (OR: 0.76 per unit increase in log odds of having BE, 95% CI: 0.70-0.83) and higher (OR: 0.75, 95% CI: 0.63-0.90) were significantly associated with a lower risk of BE. No associations of other genera of gut microbiota with BE were noted, apart from suggestive associations of higher (OR: 0.77; 95% CI: 0.61-0.99), higher (OR: 0.89; 95% CI: 0.80-0.99), and higher (OR: 0.76; 95% CI: 0.56-1.02) with a lower risk of BE, and higher (OR: 1.15; 95% CI: 0.99-1.33) with a higher risk of BE. This study suggests that higher and higher might protect against BE.
ISSN:1664-8021
1664-8021
DOI:10.3389/fgene.2022.894900